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Although it is well-established that macrophages can occur in distinct activation states, the molecular
characteristics of differentially activated macrophages, and particularly those of alternatively activated
macrophages (aaMf), are still poorly unraveled. Recently, we demonstrated that the expression of
FIZZ1 and Ym is induced in aaMf as compared with classically activated macrophages (caMf),
elicited in vitro or developed in vivo during infection with Trypanosoma brucei brucei. In the present
study, we analyzed the expression of FIZZ1 and Ym in caMf and aaMf elicited during Trypanosoma
congolense infection and show that the use of FIZZ1 and Ym for the identiﬁcation of aaMf is not
limited to T. b. brucei infection and is independent of the organ sources from which macrophages are
obtained. We also demonstrate that FIZZ1 can be used to discriminate between different populations of
aaMf. Furthermore, we studied the effects of various stimuli, and combinations thereof, on the
expression of FIZZ1 and Ym in macrophages from different mouse strains and demonstrate that
regulation of the expression of FIZZ1 and Ym in macrophages is not dependent on the mouse strain.
Finally, we show that these genes can be used to monitor the macrophage activation status without the
need to obtain pure macrophage populations.
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INTRODUCTION
As for many other cell types of the immune system,
macrophages can exist under the form of different subsets
exhibiting different functional and molecular properties.
The emergence of different macrophage subsets is
primarily due to differences in the environments to which
macrophages are exposed (Henson and Riches, 1994;
Erwig et al., 1998; for review, see Goerdt and Orfanos,
1999).Thebest-studiedmacrophagesubsetsareclassically
activated macrophages (caMf) that differentiate in the
presence of proinﬂammatory stimuli such as type I
cytokinesandLPS(GoerdtandOrfanos,1999).Classically
activated macrophages possess anti-microbial, anti-pro-
liferative and cytotoxic properties, partly due to their
ability to secrete nitric oxide (NO) and proinﬂammatory
cytokines such as TNF, IL-1 and IL-6 (Janeway and
Travers,1996).AlthoughcaMfareimportantcomponents
of host defense in the ﬁght against various pathogens, the
persistence or escalation of the inﬂammatory processes
mediated by caMf can result in immunopathology
(Gazzinelli et al., 1996; Li et al., 1999). Thus, for an
immuneresponse tobeasbeneﬁcial tothe hostaspossible,
the resolution of inﬂammation is of crucial importance
(Hunteret al.,1997; Namangala etal.,2000; De Baetselier
et al., 2001). Type II immune response mediators, such as
IL-4andglucocorticoids,antagonizeclassicalmacrophage
activation and induce the development of alternatively
activated macrophages (aaMf) (Goerdt and Orfanos,
1999). In aaMf, inducible nitric oxide synthase (iNOS),
catalyzing the production of NO and L-citrulline from
L-arginine, is suppressed; instead, in an alternative
pathway, catalyzed by arginase, L-arginine is converted
to L-ornithine and urea (Munder et al., 1998). Moreover,
alternatively activated macrophages secrete anti-inﬂam-
matory mediators such as TGF-b and IL-10 (Goerdt and
Orfanos, 1999). On this basis, aaMf have been considered
to secure the balance between pro- and anti-inﬂammatory
reactions during type I cytokine-driven inﬂammatory
responses (Goerdt and Orfanos, 1999). In addition, it has
been reported that aaMf exhibit a high endo- and
phagocytotic capacity (Goerdt and Orfanos, 1999), can
promoteangiogenesis(Kodeljaetal.,1997)andcontribute
to wound healing (Gratchev et al., 2001). However, the
exact functional properties of aaMf in vivo remain
unclear. Indeed, aaMf have been found to be associated
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(Loke et al., 2000a; Falcone et al., 2001). Therefore, it
cannot be excluded that, under these circumstances, aaMf
support the development of pathology. Finally, because of
their ability to act as antigen presenting cells as well as to
secrete immunosuppressive and/or immunomodulatory
mediators,caMfandaaMfcaninﬂuencethedevelopment
and maintenance of adaptive immune responses (Janeway
and Travers, 1996; Schebesch et al., 1997; Namangala
et al., 2000; Loke et al., 2000b).
The molecular differences between differentially
activated macrophages have slowly begun to be unraveled.
For example, expression of the three species of Fcg
receptor on macrophages was found to be induced by IFN-
g but inhibited by IL-4 (Becker and Daniel, 1990; Te
Velde et al., 1990). On the other hand, the macrophage
mannose receptor (Stein et al., 1992), 15-lipoxygenase
(Conrad et al., 1992), ﬁbronectin and the extracellular
matrix protein bIG-H3 (Gratchev et al., 2001) have been
s h o w nt ob eu p - r e g u l a t e di nI L - 4 - i n d u c e da a M f.
In human macrophages, the surface markers MS-1 high
molecular weight protein (MS-1-HMWP) (Goerdt et al.,
1993), the scavenger receptor CD163 (RM3/1 antigen)
(Buechler et al., 2000) and the chemokine AMAC-1
(Kodelja et al., 1998) are thus far the most commonly used
markers to characterize the alternative pathway of
activation. Molecular characterization of aaMf and
caMf has so far been mainly carried out using
differentially activated macrophages obtained by in vitro
steering of human peripheral blood monocytes. However,
the in vivo environments in which macrophages develop
are far more complex than the environments generated
in vitro. Hence, the differential gene expression data
obtained from in vivo-elicited aaMf and caMf may be
more physiologically relevant than those obtained from
in vitro-induced macrophages. In vivo murine models can
be used to study the mechanisms underlying the functional
properties of different macrophage populations and their
differential activation, in ways that would not be
conceivable in humans. Further characterization of the
molecular repertoire of differentially activated macro-
phages is a prerequisite for a better understanding of the
mode of action and differential activation of macrophages,
which in turn may open new avenues towards the
development of novel diagnostic and therapeutic
approaches. However, in mouse, molecular markers for
the identiﬁcation of different macrophage populations are
scarce and discrimination between murine caMf and
aaMf has so far been based mainly on differential
argininemetabolismviaiNOSandarginase(Munderetal.,
1998). Recently, we focused on the identiﬁcation of genes
that are differentially expressed in aaMf versus caMf
elicited during murine PLC
2/2 Trypanosoma brucei
brucei infection (Raes et al., 2002). In this infection
model, correlating with a switch from a type I cytokine
environment in the early stage of infection to a type II
cytokine environment in the late and chronic phases,
macrophages from early stage-infected mice are caMf,
and those from the late and chronic stages of infection are
aaMf (De Baetselier etal., 2001; Namangala et al.,2001).
Using this infection model, we demonstrated that the
expression of FIZZ1, also referred to as RELMa,
(Holcomb et al., 2000; Steppan et al., 2000) and Ym
(Guo et al., 2000; Webb et al., 2001; Chang et al., 2001a)
is induced strongly in in vivo-elicited adherent peritoneal
and splenic aaMf as compared to caMf (Raes et al.,
2002).
Inthepresentstudy,weanalyzedtheexpressionpatterns
of FIZZ1 and Ym in different macrophage populations
elicited during Trypanosoma congolense infection. In
contrast to T. b. brucei, that is a tissue-inﬁltrating parasite,
T. congolense remains mainly in the vasculature (Black
and Seed, 2001). Moreover, whereas essentially the same
course of infection is recorded upon inoculation of T. b.
brucei in C57Bl/6 or BALB/c mice, there is a clear
difference in susceptibility of these two mouse strains
towardsinfectionwithT.congolense(Uzonnoetal.,1999).
Hence, in this study, we evaluated FIZZ1 and Ym as
markers for macrophage activation status in models for
resistance versus susceptibility towards parasite infection.
Furthermore, we tested the effects of type I and type II
stimuli on the expression of FIZZ1 and Ym in
macrophages derived from different mouse strains.
RESULTS
Differential Expression of FIZZ1 and Ym in
Macrophages Elicited During T. congolense Infection
In a model of T. congolense infection, BALB/c mice are
considered as extremely susceptible, dying within 8 ^ 2
days of infection, following uncontrolled exponential
parasite growth (Uzonna et al., 1999). Spleen cells from
early-stage (6 days post-infection) T. congolense-infected
BALB/c mice secreted high levels of IFN-g, IL-4 and
IL-13 (Fig. 1A). Splenic macrophages developed in this
mixed type I/type II cytokine environment exhibited high
levels of both arginase activity and NO secretion,
reﬂecting a mixed classically/alternatively activated
phenotype (Fig. 1B, C). As compared with splenic
macrophages from non-infected BALB/c mice, Ym, but
not FIZZ1, was strongly induced in splenic macrophages
from early stage-infected BALB/c animals (Fig. 1D).
In contrast to BALB/c mice, C57Bl/6 mice are resistant
to T. congolense infection, exhibiting low parasitemia and
a survival time of 160 ^ 25 days (Uzonno et al., 1999). In
T. congolense-infected C57Bl/6 mice, the level of IFN-g
produced by spleen cells was higher in the early stage
(6 days post-infection) of infection than in the late stage
(8 weeks post-infection) while IL-4 and IL-13 secretions
were higher in the late than in the early stage (Fig. 1A).
Therefore, spleen cells from early- and late-stage
T. congolense-infected C57Bl/6 mice exhibit predominant
type I and predominant type II cytokine proﬁles,
respectively. Accordingly, based on arginase activity
G. RAES et al. 152FIGURE 1 Cytokine proﬁles, macrophage activation status and FIZZ1/Ym expression in the spleens of T. congolense-infected mice. (A) Cytokine
proﬁlesof the spleens from early-stage T. congolense-infected BALB/c mice and early-and late-stageT. congolense-infected C57Bl/6mice. The data are
presented as the ratio of cytokine secretion between spleen cells from infected (I) and non-infected (N) mice. The dotted line indicates an I/N ratio of1 .
(B) Arginase activity and (C) nitric oxide (NO) secretion levels in splenic macrophages from non-infected (N), early stage (E) and late phase (L)
T. congolense-infected animals. (D) Semi-quantitative RT-PCR analysis of FIZZ1 and Ym expression in adherent splenocytes from non-infected
(lane N), early (lane E) and late (lane L) stage T. congolense-infected C57BL/6 or BALB/c mice. The number of PCR cycles, indicated in parenthesis,
was optimized so that PCR analysis could be carried out within the linear phase of ampliﬁcation. The house-keeping gene b-actin was used to compare
the amount of cDNA templates used.
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early and late stages of infection of these C57Bl/6 mice
can be classiﬁed as caMf and aaMf, respectively
(Fig. 1B, C). As compared with macrophages from non-
infected C57Bl/6 animals and caMf developed in the
early stage of T. congolense infection, the expression of
FIZZ1 and Ym was strongly induced in splenic aaMf
elicited in the late stage of infection (Fig. 1D).
Regulation of the Expression of FIZZ1 and Ym in
Macrophages is Independent of Mouse Strain
Results in the preceding section demonstrate that, during
T. congolense infection, the expression of FIZZ1 was
induced in macrophages developed during the late stage of
infection in C57Bl/6 mice, but not in macrophages elicited
during the early stage of infection in BALB/c mice,
despite the fact that both macrophage populations
exhibited high arginase activity and expressed high levels
of Ym. To test whether the difference in the expression of
FIZZ1 in these aaMf populations is due to differences in
the regulation of this gene in the two mouse strains
analyzed, we investigated the effects of various stimuli on
the expression of FIZZ1 in macrophages isolated from
BALB/c and C57Bl/6 mice.
Adherent PEC from non-infected BALB/c and C57Bl/6
mice elicited with thioglycollate were steered in vitro and
their activation status was determined by measuring the
arginase activity and NO production (Fig. 2A, B).
As compared to non-stimulated cells, in both mouse
strains, stimulation with IL-4, IL-13, or IL-4 plus IL-13
resulted in enhancement of arginase activity but had no
effect on NO secretion. In C57Bl/6, but not in BALB/c
mice, IL-10 augmented arginase activity of macrophages,
although to a lesser extent than IL-4 or IL-13. IL-10 had
no effect on IL-4-induced arginase activity in both mouse
strains. IL-10 induction of arginase activity, observed in
macrophages from C57Bl/6 mice, was not affected by the
simultaneous addition of IFN-g. In contrast, IFN-g
completely inhibited IL-4 induction of arginase activity
in both strains. Simultaneous addition of LPS partially
inhibited IL-4-induced arginase activity in BALB/c mice
but had no such effect in C57Bl/6 mice (Fig. 2A). Hence,
in both BALB/c and C57Bl/6 mice, IL-4 induction of
arginase activity was more efﬁciently inhibited by
simultaneous addition of IFN-g than LPS. As shown in
Fig. 2B, in C57Bl/6, as well as in BALB/c mice,
stimulation with LPS, IFN-g, or a combination thereof,
resulted in increase in NO secretion, but did not affect the
arginase activity. In both strains, IL-4 partially diminished
LPS-, but not IFN-g-induced, NO secretion, whereas IL-
10 nearly completely inhibited induction of NO by IFN-g.
RT-PCR analysis revealed that, as compared with non-
stimulated macrophages, stimulation with IL-4, IL-13,
IL-4 plus IL-13, or IL-4 plus IL-10 resulted in the
induction of FIZZ1 and Ym in macrophages from both
BALB/c and C57Bl/6 mice (Fig. 2C, D). In macrophages
from both mouse strains, the type I stimulus IFN-g
antagonized completely the effect of IL-4 on the
expression of both FIZZ1 and Ym. LPS completely
inhibited IL-4-induced FIZZ1, but only partially sup-
pressed IL-4 induction of Ym in both strains (Fig. 2C, D).
Collectively, the above data showed that the in vitro
steering conditions inducing high expression levels of
both FIZZ1 and Ym, resulted in high arginase activity and
low NO secretion levels. The expression of Ym, but not
FIZZ1, was also elevated in macrophages treated with
IL-4 plus LPS, exhibiting increased levels of both arginase
activity and NO secretion. The above experiments also
indicated that, at the concentrations of modulators that
were tested, macrophages derived from C57Bl/6 and
BALB/c mice do not differ in the regulation of FIZZ1 and
Ym expression upon in vitro activation by the various
immune modulators.
FIZZ1 and Ym as Tools to Monitor the Macrophage
Activation Status using Total PEC
As compared with caMf, both in vitro- and in vivo-
elicited aaMf, puriﬁed by adherence, express high levels
of FIZZ1 and Ym. To test whether these genes can be used
to characterize the macrophage activation state without
the need to enrich the cell populations for macrophages,
we used total PEC from non-infected, early- and chronic-
stage PLC
2/2 T. b. brucei-infected F1 mice. As shown in
Fig. 3A, B, peritoneal cells from the early stage of
infection exhibited low arginase activity and high level of
NO secretion, reﬂecting the presence of caMf. Peritoneal
cells from the chronic stage of infection secreted marginal
levels of NO and displayed high arginase activity,
reﬂecting the presence of aaMf. Semi-quantitative RT-
PCR analysis revealed that, as compared to total PEC from
non-infected and early-stage PLC
2/2 T. b. brucei-infected
mice, the expression of FIZZ1 and Ym in total PEC from
chronic-stage PLC
2/2 T. b. brucei-infected animals was
notably high (Fig. 3C).
DISCUSSION
FIZZ1 (found in inﬂammatory zone) is a resistin-like
secreted protein which is markedly up-regulated in the
lung during allergic pulmonary inﬂammation (Holcomb
et al., 2000; Steppan et al., 2000). Ym is a chitinase-like
secretory lectin that forms crystals in the lungs of mice
exhibiting hyperactivity of alveolar macrophages (Guo
et al., 2000; Sun et al., 2001; Chang et al., 2001a) and is
up-regulated in the lung during the development of allergy
(Webb et al., 2001). Recently, we demonstrated that the
expression of FIZZ1 and Ym genes is induced in aaMf
developed during PLC
2/2 T. b. brucei infection (Raes
et al., 2002). In the present study, we focused on the
analysis of the expression of these genes in macrophages
G. RAES et al. 154elicited during T. congolense infection. It should
be remarked that, so far, two different isotypes of Ym,
termed Ym1 and Ym2, have been characterized
(Guo et al., 2000; Chang et al., 2001a; Sun et al., 2001;
Webb et al., 2001). The primers used in our studies
amplify both Ym1 and Ym2 sequences. Therefore, our
experiments address the expression of Ym in general and
not of its particular isotypes.
We showed that, during infection of C57Bl/6 mice with
T. congolense, correlating with a switch from a
predominant type I cytokine proﬁle in the early stage of
infection to a predominant type II cytokine environment in
the late phase, splenic macrophages from the early stage
are caMf, and those from the late phase are aaMf.
As is the case with aaMf elicited during PLC
2/2 T. b.
brucei infection (Raes et al., 2002), splenic aaMf induced
during the late stage of infection of C57Bl/6 mice with
T. congolense exhibit notably high levels of FIZZ1 and
Ym expression as compared with macrophages from non-
infected and early stage-infected animals. This shows that
the use of FIZZ1 and Ym to identify aaMf is not limited
to PLC
2/2 T. b. brucei infection. Moreover, the enhanced
expression of FIZZ1 and Ym in both peritoneal
(Noe ¨l et al., 2002) and splenic macrophages
(documented in this paper) elicited during infection of
C57Bl/6 mice with T. congolense further conﬁrms our
previous ﬁndings in the PLC
2/2 T. b. brucei model (Raes
et al., 2002) that the expression of these genes is
FIGURE 2 Activation status of in vitro-elicited differentially activated macrophages. Adherent thioglycollate-elicited peritoneal macrophages from
BALB/c and C57Bl/6 mice were cultured without any stimuli (control) or in the presence of the indicated stimuli. (A) Arginase activity. (B) Nitric oxide
(NO) secretion levels. (C and D) Semi-quantitative RT-PCR analysis of the expression of FIZZ1 and Ym in macrophages from BALB/c (C) or C57Bl/6
(D) mice. The number of PCR cycles, indicated in parenthesis, was optimized so that PCR analysis could be carried out within the linear phase of
ampliﬁcation. The house-keeping gene b-actin was used to compare the amount of cDNA templates used.
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phages are obtained.
Spleens of early-stage T. congolense-infected BALB/c
mice exhibited a mixed type I/type II cytokine proﬁle and
harbored macrophage populations which were similar to
aaMf from late-stage T. congolense-infected C57Bl/6
mice in that their arginase activity and Ym expression
level were high. On the other hand, FIZZ1 was induced
strongly in aaMf from late-stage T. congolense-infected
C57Bl/6 mice but not in macrophages from early-stage
T. congolense-infected BALB/c mice. Therefore, FIZZ1
may discriminate between different populations of aaMf.
Interestingly, in these BALB/c and C57Bl/6 models of
T. congolense infection, a strong induction of FIZZ1 is
associated with resistance. Although, in vitro, IFNg
blocked the IL-4-induced expression of arginase, Ym and
FIZZ1, the induction of arginase activity and Ym
expression, but not FIZZ1 expression, in macrophages
from early-stage T. congolense-infected BALB/c mice,
suggests that IFN-g suppresses more efﬁciently the
expression of FIZZ1 than YM and arginase in these
in vivo-elicited aaMf.
In general, analysis of in vitro-stimulated macrophages
revealed that, in regard to FIZZ1 and Ym expression,
macrophages derived from C57Bl/6 and BALB/c mice do
not differ in their responses to the same stimuli. Thus, the
difference in the expression of FIZZ1 between macro-
phages from early-stage T. congolense-infected BALB/c
mice and macrophages from late-stage T. congolense
C57Bl/6 mice is probably due to the differences in the
cytokine environments in which macrophages develop.
Indeed, in in vitro stimulation experiments, type II stimuli
such as IL-4 and IL-13, inducing high arginase activity but
no NO secretion, increased the expression levels of both
FIZZ1 and Ym, whereas a combination of type I/type II
stimuli (LPS plus IL-4), that augmented both arginase
activity and NO secretion, enhanced the expression of Ym
but not FIZZ1.
In vitro stimulation of macrophages from C57Bl/6
mice, but not from BALB/c mice, with IL-10 increased
arginase activity, but did not induce detectable levels of
FIZZ1 and Ym expression. Yet, the arginase activity
induced by IL-10 was lower than the arginase activities
induced by IL-4 or IL-13. Thus, it might be speculated that
macrophages treated with IL-10 do not express FIZZ1 and
Ym because they are not enough polarized towards an
alternatively activated phenotype. Alternatively, it is
possible that IL-10 induces a population of aaMf different
from those expressing FIZZ1 and/or Ym.
Finally, we demonstrated that the differential
expression of FIZZ1 and Ym can also be detected in
total PEC, without isolating the macrophages via
adherence. This can have important implications for
situations where the amount of cells is too little to allow
efﬁcient puriﬁcation. In addition, these results exclude the
possibility that the observed differences in FIZZ1 and Ym
expression are due to the induction of these genes during
adherence.
In conclusion, the results of this study are in agreement
with other studies showing a direct correlation between a
type II cytokine environment and high expression of
FIZZ1 and/or Ym (Falcone et al., 2001; Chang et al.,
2001a; Webb et al., 2001; and Nair et al., 2003).
We demonstrated that FIZZ1 and Ym constitute useful
markers for the identiﬁcation of both in vitro-elicited
aaMf and aaMf derived from different organs in
different infection models. This highlights that PLC
2/2
T. b. brucei infection, originally used for the molecular
characterization of aaMf, leading to the identiﬁcation of
FIZZ1 and Ym as markers for alternative macrophage
activation, is an appropriate in vivo model for the
identiﬁcation of genes that are differentially expressed in
aaMf versus caMf. Such identiﬁcation is a critical step in
addressing the contribution and effector mechanisms of
aaMf in the various biological processes with which they
are associated, including immune suppression and
immune deviation during parasitic infection (Loke et al.,
2000a,b), cancer (Mills et al., 1992; Chang et al., 2001b),
pulmonary inﬂammation (Guo et al., 2000) and wound
healing (Gratchev et al., 2001).
FIGURE 3 Macrophage activation status during infection with PLC
2/2 T. b. brucei. (A) Arginase activity and (B) nitric oxide (NO) secretion in total
PEC from non-infected, early-stage and chronic-stage infected F1 mice. (C) Semi-quantitative RT-PCR analysis of FIZZ1 and Ym expression in total
PEC from non-infected, early-stage and chronic-stage infected mice. The number of PCR cycles, indicated in parenthesis, was optimized so that PCR
analysis could be carried out within the linear phase of ampliﬁcation. The house-keeping gene ribosomal protein S12 was used to compare the amount of
cDNA templates used.
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Parasites and Animals
Female 8–12 weeks-old F1 (C57Bl/6 £ BALB/c),
BALB/c and C57Bl/6 mice (Harlan, Zeist, The
Netherlands) were inoculated intraperitoneally with 5 £
103 phospholipase C-deﬁcient mutant (PLC
2/2) T. b.
brucei (Webb et al., 1997) or Tc13 T. congolense (kindly
provided by Dr Henry Tabel, University of Saskatchewan,
Canada).
Preparation of Macrophage Populations
Peritoneal exudate cells (PEC) from PLC
2/2 T. b. brucei-
infected mice were collected in the early (6 days post-
infection) or chronic (4–5 months post-infection) stage
of infection. Spleen cells (SPC) from T. congolense-
infected animals were harvested in the early (6 days post-
infection) or late (8 weeks post-infection) phase of
infection. The infections were timed so that at the time of
PEC/SPC harvest, the mice at different stages of infection
were age-matched. All cell cultures were performed in
RPMI 1640 medium supplemented with 10% heat-
inactivated fetal calf serum, 5 £ 1025 M 2-mercapto-
ethanol, 2mM L-glutamine, 100U/ml penicillin,
100mg/ml streptomycin and 0.1mm non-essential amino
acids (all from GIBCO BRL). To obtain adherent cells,
2 £ 107 PEC or 10
8 SPC were dispensed in a 10-cm tissue
culture dish (Falcon) and incubated at 378C for 2–3h in a
humidiﬁed incubator containing 5% CO2. Non-adherent
cells and contaminating parasites were then washed away
with RPMI 1640 pre-warmed at 378C.
For in vitro stimulation, the adherent fraction of PEC
from C57Bl/6 or BALB/c mice injected intraperitoneally
with 3ml of thioglycollate broth (BioMe ´rieux, Marcy
l’Etoile, France) 4 days prior to collection was cultured in
the presence of the indicated stimuli for 48h at the
following ﬁnal concentrations: 5ng/ml IL-13 (R&D
Systems), 100U/ml IL-4 (Pharmingen), 100U/ml IFN-g
(Pharmingen), 100U/ml IL-10 (Pharmingen) and
100ng/ml LPS (from E. coli Serotype 055:B5, Sigma).
Quantiﬁcation of Cytokines
Cytokines were quantiﬁed in cell culture supernatants
using speciﬁc sandwich ELISAs for IFN-g,I L - 4
(PharMingen) or IL-13 (R&D Systems). ELISAs were
performed as recommended by the suppliers. Reported
cytokine levels are the maximal levels, i.e. observed after
1 day of culture for IL-4 and IL-13, and 3 days of culture
for IFN-g.
Quantiﬁcation of NO and Arginase Activity
Levels of NO in adherent cell culture supernatants were
determined by quantifying NO2 using Greiss reagent as
described (Namangala et al., 2001). Arginase activity was
measured as previously reported (Namangala et al., 2001).
Brieﬂy, 10
6 cells were lyzed with 100ml of 0.1% Triton
X-100. After 30min shaking at room temperature,
arginase was activated in the presence of 100ml2 5m M
Tris–HCl pH 7.5 and 35ml 10mm MnCl2 (10min, 568C).
L-Arginine hydrolysis was conducted by incubating the
cell lysate with 100ml of 0.5M L-arginine (pH 9.7) at
378C for 1h. The reaction was stopped by addition of
800mlH 2SO4 (96%)/H3PO4 (85%)/H2O (1v/3v/7v). The
produced urea was quantiﬁed at 540nm after addition of
40mlo fa-isonitrosopropiophenone (dissolved in 100%
ethanol) followed by heating at 1008C for 20min. One unit
of enzyme was deﬁned as the amount that catalyses the
formation of 1mmol of urea per min.
General Molecular Techniques
Unless otherwise noted, nucleic acids were handled
according to standard protocols (Sambrook et al., 1989).
Total RNA was prepared using Trizol reagent (GIBCO
BRL).
Semi-quantitative Reverse Transcriptase (RT)-PCR
One microgram of DNase-treated total RNA was reverse-
transcribed using oligo(dT) and Superscript II reverse
transcriptase (GIBCO BRL) following the manufacturers’
recommendations. Each PCR cycle consisted of 1min
denaturation at 948C, 45s annealing at 548C, and 1min
extension at 728C. The PCR primers were FIZZ1 sense
(50-TCCCAGTGAATACTGATGAGA-30), FIZZ1 anti-
sense (50-CCACTCTGGATCTCCCAAGA-30), Ym sense




tein S12 sense (50-GGAAGGCATAGCTGCTGGAG-
GTGT-30), and ribosomal protein S12 antisense
(5-CCTCGATGACATCCTTGGCCTGAG-30).Theampli-
con sizes were 213, 304, 381 and 367 bp for FIZZ1, Ym,
b-actin and ribosomal protein S12, respectively. The Ym
primers described above amplify both Ym1 and Ym2
sequences. The amount of template cDNA and the number
of PCR cycles were optimized so that the analysis of PCR
products could be carried out within the linear phase of
ampliﬁcation.b-actinorribosomalproteinS12wasusedas
control to ensure that the observed differences in the
expression levels of each gene in different cells were not
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